Vlad A - Search Results

1

Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms.

Zhang L, Vlad A, Milcarek C, Finn OJ. Zhang L, et al. Among authors: vlad a. Cancer Immunol Immunother. 2013 Mar;62(3):423-35. doi: 10.1007/s00262-012-1325-2. Epub 2012 Sep 2. Cancer Immunol Immunother. 2013. PMID: 22941036 Free PMC article.

2

Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses.

Barratt-Boyes SM, Vlad A, Finn OJ. Barratt-Boyes SM, et al. Among authors: vlad a. Clin Cancer Res. 1999 Jul;5(7):1918-24. Clin Cancer Res. 1999. PMID: 10430099

3

The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells.

Hiltbold EM, Vlad AM, Ciborowski P, Watkins SC, Finn OJ. Hiltbold EM, et al. Among authors: vlad am. J Immunol. 2000 Oct 1;165(7):3730-41. doi: 10.4049/jimmunol.165.7.3730. J Immunol. 2000. PMID: 11034378

4

Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells.

Vlad AM, Muller S, Cudic M, Paulsen H, Otvos L Jr, Hanisch FG, Finn OJ. Vlad AM, et al. J Exp Med. 2002 Dec 2;196(11):1435-46. doi: 10.1084/jem.20020493. J Exp Med. 2002. PMID: 12461079 Free PMC article.

5

Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Correa I, Plunkett T, Vlad A, Mungul A, Candelora-Kettel J, Burchell JM, Taylor-Papadimitriou J, Finn OJ. Correa I, et al. Among authors: vlad a. Immunology. 2003 Jan;108(1):32-41. doi: 10.1046/j.1365-2567.2003.01562.x. Immunology. 2003. PMID: 12519300 Free PMC article.

6

MUC1 immunobiology: from discovery to clinical applications.

Vlad AM, Kettel JC, Alajez NM, Carlos CA, Finn OJ. Vlad AM, et al. Adv Immunol. 2004;82:249-93. doi: 10.1016/S0065-2776(04)82006-6. Adv Immunol. 2004. PMID: 14975259 Review. No abstract available.

7

Glycoprotein tumor antigens for immunotherapy of breast cancer.

Vlad AM, Finn OJ. Vlad AM, et al. Breast Dis. 2004;20:73-9. doi: 10.3233/bd-2004-20109. Breast Dis. 2004. PMID: 15687709 Review.

8

Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.

Ryan SO, Vlad AM, Islam K, Gariépy J, Finn OJ. Ryan SO, et al. Biol Chem. 2009 Jul;390(7):611-8. doi: 10.1515/BC.2009.070. Biol Chem. 2009. PMID: 19426130 Free PMC article.

9

Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.

Budiu RA, Mantia-Smaldone G, Elishaev E, Chu T, Thaller J, McCabe K, Lenzner D, Edwards RP, Vlad AM. Budiu RA, et al. Among authors: vlad am. Cancer Immunol Immunother. 2011 Jul;60(7):975-84. doi: 10.1007/s00262-011-1010-x. Epub 2011 Apr 2. Cancer Immunol Immunother. 2011. PMID: 21461842 Free PMC article.

10

MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location.

Tirodkar TS, Budiu RA, Elishaev E, Zhang L, Mony JT, Brozick J, Edwards RP, Vlad AM. Tirodkar TS, et al. Among authors: vlad am. PLoS One. 2014 Jul 31;9(7):e102409. doi: 10.1371/journal.pone.0102409. eCollection 2014. PLoS One. 2014. PMID: 25078979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters